Nursing Care and Education in Liver Tumors

Yasemin TOKEMa
aİzmir Kâtip Çelebi University Faculty of Health Science, Department of Nursing, Division of Internal Medicine Nursing, İzmir, Türkiye

Tokem Y. Nursing care and education in liver tumors. In: Oğuz S, ed. Nursing Care and Education in Gastrointestinal System Diseases. 1st ed. Ankara: Türkiye Klinikleri; 2024. p.47-53.

ABSTRACT
In recent years, there has been a numerical increase in the detection of liver tumors. The family history and medical history of the patient, comprehensive physical examination, radiological examinations, laboratory tests, and biopsy are used in the screening and diagnosis of tumors of the liver. Treatment options may include surgery, chemotherapy, radiotherapy and targeted therapies. In various treatment guidelines, the importance of multidisciplinary teamwork in the treatment and management of liver tumors has been shown as strong evidence. In liver tumors, nursing management is important at all stages of the disease process, including management of the patient’s current symptoms, identification of risk factors, diagnosis, and planning and implementation of treatment and care, and patient education. As a member of the health care team, the nurse takes the patient and family at the center of the team and performs the roles of caregiver, counselor, educator, researcher, patient advocate, and care manager and coordinator.

Keywords: Liver neoplasms, experimental; nursing; patient education as topic; carcinoma, hepatocellular

Referanslar

  1. Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598-606. [Crossref]  [PubMed]  [PMC]
  2. Colombo M. EASL Clinical Practice Guidelines on the Management of Benign Liver Tumors. Clin Liver Dis (Hoboken). 2020;15(4):133-5. [Crossref]
  3. Boyle DA. Hepatocellular Carcinoma: Implications for Asia-Pacific Oncology Nurses. Asia Pac J Oncol Nurs. 2017;4(2):98-103. [Crossref]  [PubMed]  [PMC]
  4. Özdemir M, Yücel S. Hepatoselüler Kanser Tedavisi: Perkütan Ablasyon Tedavileri. Türkiye Klinikleri J Gastroenterohepatol. 2015;22(2):32-8. [Crossref]
  5. Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557-88. [Crossref]  [PubMed]  [PMC]
  6. Choi S, Kim BK, Yon DK, Lee SW, Lee HG, Chang HH, et al. Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990-2019: A DALY-based analysis of the Global Burden of Disease 2019 study. Clin Mol Hepatol. 2023;29(2):433-52. [Crossref]  [PubMed]  [PMC]
  7. Ertuğrul G,Yanaral T. Living donor liver transplantation in hepatocellular carcinoma: A single-center experiences. J Surg Med. 2019;3(4):320-3. [Crossref]
  8. Tolunay T., Kaygusuz S, Keskinkılıç B, Özsarı S, Gökler ME. Türkiye Kanser İstatistikleri 2018. TC Sağlık Bakanlığı Yayınları, Ankara 2022. Kanser_Rapor_2018.pdf (saglik.gov.tr)
  9. Mitchell T, Jeffrey GP, de Boer B, MacQuillan G, Garas G, Ching H, et al. Type and Pattern of Alcohol Consumption is Associated With Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease. Am J Gastroenterol. 2018;113(10):1484-93. [Crossref]  [PubMed]
  10. Lewis SM, Dirksen SR, Heitkemper MM, Bucher L. Medical Surgical Nursing: Asssessment and Management of Clinical Problems. 9th ed. Canada: Elsevier Company; 2014.
  11. Chih-Yi Sun V, Sarna L. Symptom management in hepatosellular carcinoma. Clin J Oncol Nurs. 2008;12(5):759-66. [Crossref]  [PubMed]  [PMC]
  12. Yazıcı O, Bahar K. Hepatosellüler karsinomda yeni tanı ve tedavi yöntemleri. Güncel Gastroenteroloji. 2008;12(1):47-52.
  13. Singal AG, Llovet JM, Yarchoan M, Mehta N, Heimbach JK, Dawson LA, et al. AASLD practice guidance on prevention, diagnosis and treatment of hepatocellular carcinoma. Hepatology. 2023;78(6):1922-65. [Crossref]  [PubMed]
  14. Solbiati LA, Arai Y. Interventional oncology of liver tumors: how it all started and where are we now. Br J Radiol. 2022;95(1138):20220434. [Crossref]  [PubMed]  [PMC]
  15. Izzo F, Granata V, Grassi R, Fusco R, Palaia R, Delrio P, et al. Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update. Oncologist. 2019;24(10):e990-e1005. [Crossref]  [PubMed]  [PMC]
  16. Nexavar (Sorefenib tosilat) Kullanma Talimatı, Türkiye İlaç ve Tıbbi Cihaz Kurumu [İnternet] Erişim tarihi: 15.01.2024 Erişim adresi: [Link]
  17. Mohammed MA, Mohammed HEA, El-Shishtawy MK. Effect of nursing care instructions on outcomes of patients witj hepatovellular carcinoma undergoing radiofrequency ablation therapy. Egypt J Health Care. 2020;11(3):1071-89. [Crossref]
  18. Bellini MI, Lauro A, Andrea VD, Marino IR. Benign hepatic tumors and liver transplantation: a literatüre review. Exp Clin Transplant. 2022;20(3):231-6. [Crossref]  [PubMed]
  19. Oldhafer KJ, Habbel V, Horling K, Makridis G, Wagner KC. Benign Liver Tumors. Visc Med. 2020;36(4):292-303. [Crossref]  [PubMed]  [PMC]
  20. Patel R, Mueller M, Doerr C. Alcoholic Liver Disease (Nursing) [Updated 2023 Jul 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: [Link]
  21. Seth I, Siu A, Hewitt L, Budak U, Farah B, Jaber M. Clinical Practice Guidelines For The Management Of Hepatocellular Carcinoma: A Systemic Review. J Gastrointest Canc. 2023. [Crossref]  [PubMed]  [PMC]
  22. Değer MS, Zoroğlu G. Birinci basamak sağlık kuruluşuna başvuranlarda sağlık okuryazarlığı ile kanser bilgi yükü ilişkisi. Anadolu Klin. 2021;6(1):108-17. [Crossref]